Osteologix, Inc.·4

Jun 13, 1:09 PM ET

Osteologix, Inc. 4

4 · Osteologix, Inc. · Filed Jun 13, 2007

Insider Transaction Report

Form 4
Period: 2007-06-11
Transactions
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.14/sh+500$57014,000 total(indirect: (2))
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.20/sh+8,000$9,60024,000 total(indirect: (2))
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.08/sh+11,000$11,88011,000 total(indirect: (2))
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.19/sh+2,000$2,38016,000 total(indirect: (2))
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.12/sh+2,500$2,80013,500 total(indirect: (2))
  • Award

    Common Stock, par value $.0001 per share

    2007-06-11$1.22/sh+4,000$4,88030,000 total(indirect: (2))
Footnotes (2)
  • [F1]The reporting person is a principal in Nordic Biotech K/S ("Nordic"), which is the direct owner of 15,133,061 shares, the number of shares beneficially owned does not reflect such shares held by Nordic. The reporting hereby disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  • [F2]The Reporting Person owns a 100% equity interest in CKH Invest Aps and has voting and dispositive power over the shares held by CKH Invest Aps. As a result, Mr. Hansen is deemed the beneficial owner of the shares held by the CKH Invest Aps.

Documents

1 file
  • 4
    v078160_ex.xmlPrimary